Navigation Links


Tag: "nimesulide" at medical news

Ajanta Launches World's First Once-A-Day Nimesulide Oral Formulation

...s launched its once-a-day 200mg controlled release nimesulide brand Nimlodi for arthritis. Nimlodi, which was de...g delivery system, is the world's first once-a-day nimesulide brand for the treatment of arthritis. Ajanta, which manufactures both Allopathic and Ayurvedic medic...

Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India

...d a public interest lawsuit challenging the use of nimesulide among children. The group had also objected to unapproved combinations of nimesulide and other drugs, prescribed for use in adults, as illegal. The documents they submitted to the court...

Drugs Banned worldwide still available in India

...s. Besides being available as a single ingredient, nimesulide is also available in more than 30 other drugs and as drops for children aged under1 year. All are unapproved by the drugs controller and therefore illegal. The drugs controller general of India, Ashwini Kumar, has said that the government was appoin...

Five New Anti-Inflammatory Compounds Produced By Indian Scientists

...s better than the commonly used pain drugs such as nimesulide and aspirin in terms of potency. We have already reached an understanding with a company to carry the work forward. Since these compounds are peptides, clinical studies on humans may directly begin, without animals studies ", said T P Singh, All In...

Pain-killer Drug Can Help Fight Breast Cancer

...cancer cells, scientists found that derivatives of nimesulide stopped the production of aromatase, the enzyme im...roduction, might suffer. The results suggest that nimesulide may block aromatase production only in breast tissue. Nimesulide is a non-steroidal anti-inflammator...

European Regulators Investigate Common Painkiller Drugs

...rofen, ketorolac, meloxicam, nabumetone, naproxen, nimesulide and piroxicam recommends use of smallest dose of the drugs by patients as briefly as possible, reported the online edition of Daily Mail. Millions of people regularly take such drugs, technically known as non-selective nonsteroidal anti-inflammator...

Pain Killers To Carry Warnings About Heart Attack And Stroke Risk

...n, ketorolac, meloxicam, nabumetone, naproxen, and nimesulide are the NSAIDS which have been reviewed. Low dose (400mg) ibuprofen which is an OTC drug is considered safe and will not have to include the cautionary information. The director for vigilance and risk management, Medicines and Healthcare products R...

1

Other Tagsrecipient 2recipient 3recipient 4recipient 5rabies 2cast 2cast 3doubts 2doubts 3doubts 4doubts 5fungal 2fungal 3fungal 4healthier 2healthier 3healthier 4healthier 5healthier 6healthier 7healthier 8healthier 9healthier 10dog 2wire 2
Breaking Biology News(10 mins):New inherited eye disease discovered 2Introns: A mystery renewed 2Introns: A mystery renewed 3Introns: A mystery renewed 4Experts: Disease-resistant plants enhance profits, client satisfaction 2Olympus Managed Health Care Nominated for Prestigious International Award 57106 1Olympus Managed Health Care Nominated for Prestigious International Award 57106 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 1American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 1Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 2Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 4Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 5
Other Contentsdiploiddiploiddiplotenedirectionaldirectionaldirectionaldirectionaldisaccharidesdirectdirectdirectdirectdirectdirectdirectdirectdirectdirectdistaldistaldistaldistaldistaldispersaldispersaldispersal